
Reneo Pharmaceuticals
Focused on the development of therapies for patients with genetically defined orphan diseases.
Market cap
$35.6m
Enterprise value
$36m
Share price
$2.39 RPHM
Authorizing premium user...
Focused on the development of therapies for patients with genetically defined orphan diseases.